Astria Therapeutics, Inc. — Revenue by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8318be18-13b0-400a-bc4f-3298050a102c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-051616 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001047469-19-001212 |
| FY 2017 | $500.0k | 2017-01-01 – 2017-12-31 | evidence 0001047469-19-001212 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Astria Therapeutics, Inc. — all facts · Net Income · Operating Income